Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Pilot Study That Investigates the Potential of Using OCT (Optical Coherence Tomography) Measurements of the Thickness of the Retinal Nerve Fiber Layer as a Biomarker for the Early Detection of Alzheimer's Disease.
Authors not listed
Carmel Medical Center · 2014
Abstract
The purpose of this study is to determine whether by measuring changes in the thickness of the retinal nerve fibre layer (the photosensitive layer at the back of the eye) you could predict if someone would develop Alzheimer's disease in the future. The measurement is made by OCT (ocular coherence tomography), a noninvasive and relatively inexpensive test that uses light waves to scan the back of the eye.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Anonymous. (2014). Pilot Study That Investigates the Potential of Using OCT (Optical Coherence Tomography) Measurements of the Thickness of the Retinal Nerve Fiber Layer as a Biomarker for the Early Detection of Alzheimer's Disease. <em>Carmel Medical Center</em>. https://clinicaltrials.gov/study/NCT02051244
Vancouver
Anonymous. Pilot Study That Investigates the Potential of Using OCT (Optical Coherence Tomography) Measurements of the Thickness of the Retinal Nerve Fiber Layer as a Biomarker for the Early Detection of Alzheimer's Disease. Carmel Medical Center. 2014.
BibTeX
@misc{anon2014PilotS,
title = {Pilot Study That Investigates the Potential of Using OCT (Optical Coherence Tomography) Measurements of the Thickness of the Retinal Nerve Fiber Layer as a Biomarker for the Early Detection of Alzheimer's Disease.},
author = {Anonymous},
journal = {Carmel Medical Center},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurotherapeutics 2010
Open access · OA
Astrocytes in Alzheimer's Disease
BENTHAM SCIENCE PUBLISHERS eBooks 2017
Citation only
Retinal Neurodegeneration in Alzheimer’s Disease
VIVUS LLC 2011
Open access · US-GOV
A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Safety, Tolerability and Efficacy of VI-1121 in Subjects With Alzheimer's Disease
Neurobiology of Disease 2014
Preprint · OA
Early detection of Alzheimer's disease using PiB and FDG PET
University of Wisconsin, Madison 2024
Open access · US-GOV
A Proof-of-concept Pilot Study to Determine the Efficacy of SensifyAware and Retinal Imaging in Differentiating Mild Cognitive Impairment (MCI) From Cognitively Unimpaired Controls (HC)
National Institute on Aging (NIA) 2004
Open access · US-GOV